RANKINGS

POPULAR STOCKS

Bio-Techne Corporation

NasdaqGS:TECH

Location

United States

Market Cap

USD 7.86 B

Share Price

USD 50.13

Avg Daily Volume

2,353,179

Change (1 day)

1.27%

Change (1 year)

-32.75%

Change (YTD)

-30.40%

Bio-Techne Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2025: USD -30.64 M

Bio-Techne Corporation Common Stock Issued is USD -30.64 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -214.57% change year over year. Common stock issued is cash received from issuing new shares of the company’s common stock.
  • Bio-Techne Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 26.75 M, a 432.03% change year over year.
  • Bio-Techne Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 5.03 M, a -86.73% change year over year.
  • Bio-Techne Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 37.88 M, a -173.92% change year over year.
  • Bio-Techne Corporation Common Stock Issued for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -51.24 M.
Key data
Date Common Stock Issued Common Stock Repurchased Free Cash Flow Operating Cash Flow
Market news
NasdaqGS: TECH

Bio-Techne Corporation

CEO Mr. Kim Kelderman
IPO Date Feb. 9, 1989
Location United States
Headquarters 614 McKinley Place N.E.
Employees 3,100
Sector 🏥 Health Care
Industries
Biotechnology
🔬 Chemicals & Advanced Materials
🩺 Medical Instruments
Description

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Similar companies

DHR

Danaher Corporation

USD 194.44

-0.67%

A

Agilent Technologies, Inc.

USD 115.52

-0.49%

600010.SS

Inner Mongolia Baotou Steel Union Co., Ltd.

USD 0.24

-1.69%

QGEN

Qiagen N.V.

USD 46.55

0.00%

BRKR

Bruker Corporation

USD 38.43

2.15%

TECN.SW

Tecan Group AG

USD 197.43

-0.30%

688068.SS

Beijing Hotgen Biotech Co., Ltd.

USD 18.81

-4.06%

688289.SS

Sansure Biotech Inc.

USD 2.77

-0.35%

EUZ.DE

Eckert & Ziegler Strahlen- und Medizintechnik AG

USD 72.98

-2.41%

RO.SW

Roche Holding AG

USD 338.56

1.02%

ABT

Abbott Laboratories

USD 132.41

0.10%

BSX

Boston Scientific Corporation

USD 101.37

-0.35%

TMO

Thermo Fisher Scientific Inc.

USD 392.56

0.59%

4519.T

Chugai Pharmaceutical Co., Ltd.

USD 50.10

0.95%

SHL.DE

Siemens Healthineers AG

USD 52.76

0.92%

MRK.DE

MERCK Kommanditgesellschaft auf Aktien

USD 125.22

-0.56%

BDX

Becton, Dickinson and Company

USD 168.59

-0.79%

GEHC

GE HealthCare Technologies Inc.

USD 71.89

1.05%

4543.T

Terumo Corporation

USD 18.11

0.51%

4901.T

FUJIFILM Holdings Corporation

USD 21.36

0.09%

NTRA

Natera, Inc.

USD 170.98

2.05%

DIM.PA

Sartorius Stedim Biotech S.A.

USD 232.63

2.84%

LH

Laboratory Corporation of America Holdings

USD 261.39

0.75%

WAT

Waters Corporation

USD 339.36

-0.51%

BIM.PA

bioMérieux S.A.

USD 136.66

0.21%

HLMA.L

Halma plc

USD 42.19

0.71%

WST

West Pharmaceutical Services, Inc.

USD 217.95

-0.05%

BAX

Baxter International Inc.

USD 29.80

-0.40%

IEX

IDEX Corporation

USD 175.03

-0.55%

SN.L

Smith & Nephew plc

USD 14.49

1.24%

RVTY

Revvity, Inc.

USD 94.41

0.27%

603392.SS

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.49

-2.94%

6869.T

Sysmex Corporation

USD 16.94

1.04%

EXAS

Exact Sciences Corporation

USD 52.34

-0.38%

AVTR

Avantor, Inc.

USD 13.29

1.06%

CTEC.L

ConvaTec Group Plc

USD 3.77

-0.20%

GMED

Globus Medical, Inc.

USD 57.37

-1.32%

AUROPHARMA.NS

Aurobindo Pharma Limited

USD 12.62

1.09%

4188.T

Mitsubishi Chemical Group Corporation

USD 5.19

0.07%

7701.T

Shimadzu Corporation

USD 24.55

-0.68%

RGEN

Repligen Corporation

USD 117.54

-2.87%

300832.SZ

Shenzhen New Industries Biomedical Engineering Co., Ltd.

USD 8.16

0.43%

BIO

Bio-Rad Laboratories, Inc.

USD 232.00

0.67%

DIA.MI

DiaSorin S.p.A.

USD 106.94

-0.45%

3347.HK

Hangzhou Tigermed Consulting Co., Ltd.

USD 4.59

-0.65%

000100.KS

Yuhan Corporation

USD 76.39

4.65%

LNTH

Lantheus Holdings, Inc.

USD 78.99

1.37%

BANB.SW

Bachem Holding AG

USD 70.14

-0.34%

3759.HK

Pharmaron Beijing Co., Ltd.

USD 1.94

0.43%

SFZN.SW

Siegfried Holding AG

USD 115.06

0.33%

StockViz Staff

June 21, 2025

Any question? Send us an email